Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amgen
Amgen
Biopharma’s 5 Biggest M&A Deals of 2022
BioSpace
Wed, 12/14/22 - 10:50 am
M&A
Amgen
Horizon Therapeutics
Pfizer
Biohaven
Global Blood Therapeutics
Bristol Myers Squibb
Turning Point Therapeutics
ChemoCentryx
FDA Approval of Mirati Lung Cancer Drug Sets Stage for Competition With Amgen
MedCity News
Wed, 12/14/22 - 10:19 am
Amgen
Mirati Therapeutics
Krazati
Lumakras
FDA
lung cancer
Amgen to Buy Horizon in Biotech’s Biggest Deal of 2022
BioSpace
Mon, 12/12/22 - 10:34 am
Amgen
Horizon Therapeutics
M&A
Could Amgen's Heart Disease Candidate Generate Billions in Sales?
Motley Fool
Sun, 12/11/22 - 01:26 pm
Amgen
heart disease
olpasiran
Senate Finance chair goes after Amgen again on US taxes, asking for payment specifics
Endpoints
Thu, 12/8/22 - 11:25 pm
Senate
taxes
Amgen
Amgen to push latecomer obesity drug into midstage testing
Pharmaphorum
Sun, 12/4/22 - 01:26 pm
Amgen
Novo Nordisk
Eli Lilly
obesity
clinical trials
AMG 133
With buyout on Horizon, Amgen and Sanofi eye cash plays for rare disease drug maker
Fierce Pharma
Fri, 12/2/22 - 11:13 am
Horizon Therapeutics
Sanofi
Amgen
M&A
J&J sues Amgen over plan to sell drug similar to Stelara
Business Insurance
Thu, 12/1/22 - 10:48 am
JNJ
Janssen
Amgen
legal
ulcerative colitis
patents
Stelara
Large pharmas probe takeover of Horizon Therapeutics
BioPharma Dive
Wed, 11/30/22 - 10:58 am
Horizon Pharma
M&A
JNJ
Sanofi
Amgen
Mirati is once again the subject of Big Pharma takeover talks: report
Fierce Biotech
Sun, 11/27/22 - 07:08 pm
Mirati Therapeutics
M&A
Amgen
Lumakras
Best Places to Work in Biopharma 2023 Report Reveals Most Sought-After Employers
BioSpace
Mon, 11/14/22 - 10:59 am
biotech
biopharma
employers
corporate culture
Moderna Therapeutics
Genentech
Pfizer
Amgen
AbbVie
Arrowhead Gets $250M in Royalty Deal for Cardio Drug Heading to Phase 3
MedCity News
Wed, 11/9/22 - 11:30 pm
Amgen
Arrowhead Pharmaceuticals
olpasiran
heart disease
Early data hint at benefit for Amgen’s obesity drug
BioPharma Dive
Wed, 11/9/22 - 10:32 am
Amgen
obesity
Eli Lilly
Novo Nordisk
AMG 133
Amgen to test new way to lower heart risk with large drug trial
BioPharma Dive
Mon, 11/7/22 - 11:00 am
Amgen
clinical trials
heart disease
olpasiran
Amgen's Supreme Court bid answered in long-running Repatha patent feud against Sanofi, Regeneron
Fierce Pharma
Mon, 11/7/22 - 10:55 am
Amgen
Repatha
patents
Supreme Court
Sanofi
Regeneron
What Pharma Companies Can Expect From the Influx of Humira Biosimilars
Drug Channels
Fri, 10/14/22 - 10:15 am
AbbVie
Humira
biosimilars
Amgen
Amjevita
Amgen study: Biosimilars saved the healthcare system $21B
Medical Marketing and Media
Wed, 10/12/22 - 11:38 pm
Amgen
biosimilars
Why Amgen Is Up More Than 6% Today
Motley Fool
Tue, 10/11/22 - 04:05 pm
Amgen
AMG133
obesity
R&D acceleration: Amgen opens its second largest research site, with lab and office space for 650 staff
Endpoints
Fri, 10/7/22 - 11:02 am
Amgen
R&D
SITC 2022 preview – cytokines and oral checkpoints
EP Vantage
Thu, 10/6/22 - 10:39 am
SITC
Incyte
ChemoCentryx
Amgen
cytokines
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »